Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 23.91% is in line with its 5-year average of 22.01%, near the high end of its 5-year range (16.37%–24.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.16% above its 12-month average of 23.40%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
23.91%
RETURN ON EQUITY (ROE) AVG TTM
23.40%
RETURN ON EQUITY (ROE) AVG 3Y
22.48%
RETURN ON EQUITY (ROE) AVG 5Y
22.01%
RETURN ON EQUITY (ROE) AVG 10Y
22.41%
RETURN ON EQUITY (ROE) AVG 15Y
25.92%
RETURN ON EQUITY (ROE) AVG 20Y
25.92%
CURRENT VS TTM AVG
+2.16%
CURRENT VS 3Y AVG
+6.36%
CURRENT VS 5Y AVG
+8.60%
CURRENT VS 10Y AVG
+6.69%
CURRENT VS 15Y AVG
-7.77%
CURRENT VS 20Y AVG
-7.77%
SECTOR MEDIAN · HEALTHCARE
12.21%
median of 86 covered companies
CURRENT VS SECTOR MEDIAN
+95.79%
vs the sector median at left
Encompass Health Corporation
Market Cap
$11.86B
Return on Equity (ROE)
23.91%
TTM Avg
23.40%
3Y Avg
22.48%
5Y Avg
22.01%
Market Cap
$11.48B
Return on Equity (ROE)
-114.70%
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$11.38B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$11.35B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$12.38B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$11.13B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
Market Cap
$12.64B
Return on Equity (ROE)
10.49%
TTM Avg
6.83%
3Y Avg
5.29%
5Y Avg
3.21%
Market Cap
$10.50B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$10.45B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Encompass Health Corporation (EHC) | $11.86B | 23.91% | 23.40% | 22.48% | 22.01% |
| DaVita Inc. (DVA)vs › | $11.48B | -114.70% | 329.18% | 200.63% | 164.66% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 9.77% | 10.54% | 10.84% | 19.93% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 8.63% | 6.23% | 8.78% | 10.01% |
| Tempus AI, Inc. (TEM)vs › | $12.38B | -57.18% | -651.33% | -315.37% | -198.08% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 11.23% | 7.12% | 6.90% | 7.16% |
| Penumbra, Inc. (PEN)vs › | $12.64B | 10.49% | 6.83% | 5.29% | 3.21% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.50B | 3.10% | -8.94% | -15.72% | 1.14% |
| Universal Health Services, Inc. (UHS)vs › | $10.45B | 20.31% | 18.80% | 15.17% | 15.31% |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | -0.17% | 18.91% | 22.60% | 24.60% |
ROE
23.9%
ROA
8.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 23.91% |
| 2026-03-31 | 24.16% |
| 2025-12-31 | 23.22% |
| 2025-09-30 | 22.79% |
| 2025-06-30 | 22.92% |
| 2025-03-31 | 22.91% |
| 2024-12-31 | 22.05% |
| 2024-09-30 | 21.55% |
| 2024-06-30 | 21.72% |
| 2024-03-31 | 21.63% |
| 2023-12-31 | 21.37% |
| 2023-09-30 | 22.67% |
| 2023-06-30 | 21.28% |
| 2023-03-31 | 19.60% |
| 2022-12-31 | 20.68% |
| 2022-09-30 | 22.45% |
| 2022-06-30 | 16.37% |
| 2022-03-31 | 19.88% |
| 2021-12-31 | 21.57% |
| 2021-09-30 | 22.07% |
| 2021-06-30 | 21.81% |
| 2021-03-31 | 18.40% |
| 2020-12-31 | 17.90% |
| 2020-09-30 | 17.48% |
| 2020-06-30 | 19.53% |
| 2020-03-31 | 23.78% |
| 2019-12-31 | 26.53% |
| 2019-09-30 | 23.94% |
| 2019-06-30 | 24.31% |
| 2019-03-31 | 23.65% |
| 2018-12-31 | 21.99% |
| 2018-09-30 | 24.63% |
| 2018-06-30 | 24.07% |
| 2018-03-31 | 22.83% |
| 2017-12-31 | 21.69% |
| 2017-09-30 | 22.97% |
| 2017-06-30 | 23.27% |
| 2017-03-31 | 32.88% |
| 2016-12-31 | 33.65% |
| 2016-09-30 | 31.57% |
| 2016-06-30 | 32.45% |
| 2016-03-31 | 30.58% |
| 2015-12-31 | 29.95% |
| 2015-09-30 | 28.27% |
| 2015-06-30 | 29.31% |
| 2015-03-31 | 37.20% |
| 2014-12-31 | 39.19% |
| 2014-09-30 | 42.15% |
| 2014-06-30 | 46.74% |
| 2014-03-31 | 71.08% |
| 2013-12-31 | 73.92% |
| 2013-09-30 | 48.50% |
| 2013-06-30 | 50.34% |
| 2013-03-31 | 42.64% |
| 2012-12-31 | 29.19% |
| 2012-09-30 | 76.83% |
| 2012-06-30 | 101.07% |
| 2012-03-31 | 115.86% |
| 2011-12-31 | 178.38% |
| 2002-09-30 | 7.23% |
| 2002-06-30 | 7.94% |
| 2002-03-31 | 6.01% |
| 2001-12-31 | 5.33% |
